The Master of Management Studies in Global Business and Society (GBS) provides you with tools needed to thrive in global organizations and the broad perspective to know how best to use them. Open to ...

An explicit MMS video clip, allegedly featuring Najiba, has surfaced online, sparking widespread speculation and debate on social media. The video purportedly shows a woman, believed to be Najiba ...

Hanebe/Crispy & Co opens Thursday at the corner of Central and Maize in Wichita. Jaime Green The Wichita Eagle Half of the new restaurant’s menu will be Hanebe’s, which features acai bowls ...

The network is called Lunar Surface Communication System (LSCS), and it is basically a replica of the 4G/LTE cellular technology currently used on a very large scale by the humans of Earth.

Samsung has begun a trial run of a new phone trade-in program called the Galaxy Trade-In Program. What sets it apart from previous offers is that you can get value out of your old device, even if ...

It looks like T-Mobile is now accepting customers into the free beta program for SpaceX’s cellular Starlink service—but only if you have the latest Samsung handsets. On Tuesday, a number of T ...

Smartphones that transform into sizeable tablets used to be pure sci-fi… but now bendable screens are our tech reality. Besides the obvious wow factor, these book-style foldables offer innovative ...

(AP Photo/Ted Shaffrey, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central ...

Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

Johnson & Johnson is in talks to acquire Intra-Cellular Therapies Inc., a biopharmaceutical company focused on treatments for central nervous system disorders, people familiar with the matter said. A ...

(RTTNews) - Johnson & Johnson (JNJ) and Intra-Cellular Therapies, Inc. (ITCI) announced Monday that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...